EVENTS:   Best Equity Short Ideas Conference Call 12 - Zach Shannon/Corto Capital Advisors & Craig Huber/Huber Research Partners & Thomas Beevers /Forensic Alpha & Ed Steele/Iron Blue Financials & Bill Campbell/Paragon Intel - 12 Nov 25   Will AI Deflate the World? Macro Lessons from Three Industrial Revolutions and China - Manoj Pradhan/Talking Heads Macro - 13 Nov 25     ROADSHOWS: Forest Products Sector Equity and Commodity Research With Expertise in Distressed Debt - Kevin Mason /ERA Research   •   London   12 - 14 Nov 25       Buyside to Buyside Forum and Expert Calls across TMT, Consumer, Healthcare and Fintech - Andrew Peters /Revelare Partners   •   London   17 - 19 Nov 25       Fundamental US Healthcare Short Ideas - Dr Elliot Favus /Favus Institutional Research   •   London   17 - 19 Nov 25      

Fortnightly Publication Highlighting Latest Insights From IRF Providers

Company Research

Entegris (ENTG)

Technology

Abacus Research

A high-quality, defensive, EPS compounder that will out-grow semiconductor volume growth due to trends of increasing purity and material intensity in semis. Furthermore, the benefits from the CMC acquisition could surprise on the upside and are not fully appreciated by the market (the deal represents a step change in establishing a scale advantage over ENTG's competitors). EPS growth will accelerate meaningfully in late 2023 (can compound at ~15% CAGR for the next three years), driven by revenue growth, high incremental margins and cost savings. $5.68 EPS (FY25E) x 20 PE = $114 share price.

Edition: 154

- 17 February, 2023